<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">34511734</PMID><DateRevised><Year>2022</Year><Month>07</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0947-0867</ISSN><JournalIssue CitedMedium="Print"><Volume>27</Volume><Issue>5</Issue><PubDate><Year>2021</Year></PubDate></JournalIssue><Title>Biospektrum : Zeitschrift der Gesellschaft fur Biologishe Chemie (GBCH) und der Vereinigung fur Allgemeine und Angewandte Mikrobiologie (VAAM)</Title><ISOAbbreviation>Biospektrum (Heidelb)</ISOAbbreviation></Journal><ArticleTitle>[Not Available].</ArticleTitle><Pagination><StartPage>485</StartPage><EndPage>487</EndPage><MedlinePgn>485-487</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s12268-021-1620-6</ELocationID><Abstract><AbstractText>COVID-19 still remains a severe global health threat. Despite the high-speed development of vaccines that efficiently prevent COVID-19, there are still no effective treatments of the disease once people are infected. MicroRNAs are powerful regulators of gene expression. They are intensely investigated as therapeutic targets up to the clinical stage. In addition, microRNAs can be detected in the circulation, and thus, represent promising diagnostic and prognostic biomarkers for (long)-COVID-19.</AbstractText><CopyrightInformation>&#xa9; Die Autoren 2021.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>B&#xe4;r</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Institut f&#xfc;r Molekulare und Translationale Therapiestrategien, Medizinische Hochschule Hannover, Carl-Neuberg-Str. 1, D-30625 Hannover, Deutschland.</Affiliation><Identifier Source="GRID">grid.10423.34</Identifier><Identifier Source="ISNI">0000 0000 9529 9877</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>Rebirth - Forschungszentrum f&#xfc;r Translationale Regenerative Medizin, Medizinische Hochschule Hannover, Hannover, Deutschland.</Affiliation><Identifier Source="GRID">grid.10423.34</Identifier><Identifier Source="ISNI">0000 0000 9529 9877</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Derda</LastName><ForeName>Anselm A</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Institut f&#xfc;r Molekulare und Translationale Therapiestrategien, Medizinische Hochschule Hannover, Carl-Neuberg-Str. 1, D-30625 Hannover, Deutschland.</Affiliation><Identifier Source="GRID">grid.10423.34</Identifier><Identifier Source="ISNI">0000 0000 9529 9877</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>Klinik f&#xfc;r Kardiologie und Angiologie, Medizinische Hochschule Hannover, Hannover, Deutschland.</Affiliation><Identifier Source="GRID">grid.10423.34</Identifier><Identifier Source="ISNI">0000 0000 9529 9877</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thum</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Institut f&#xfc;r Molekulare und Translationale Therapiestrategien, Medizinische Hochschule Hannover, Carl-Neuberg-Str. 1, D-30625 Hannover, Deutschland.</Affiliation><Identifier Source="GRID">grid.10423.34</Identifier><Identifier Source="ISNI">0000 0000 9529 9877</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>Rebirth - Forschungszentrum f&#xfc;r Translationale Regenerative Medizin, Medizinische Hochschule Hannover, Hannover, Deutschland.</Affiliation><Identifier Source="GRID">grid.10423.34</Identifier><Identifier Source="ISNI">0000 0000 9529 9877</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>Fraunhofer-Institut f&#xfc;r Toxikologie und Experimentelle Medizin, Hannover, Deutschland.</Affiliation><Identifier Source="GRID">grid.418009.4</Identifier><Identifier Source="ISNI">0000 0000 9191 9864</Identifier></AffiliationInfo></Author></AuthorList><Language>ger</Language><PublicationTypeList><PublicationType UI="D004740">English Abstract</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><VernacularTitle>MicroRNAs bei COVID-19: kleine Molek&#xfc;le mit gro&#xdf;em Potenzial?</VernacularTitle><ArticleDate DateType="Electronic"><Year>2021</Year><Month>09</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Biospektrum (Heidelb)</MedlineTA><NlmUniqueID>9615685</NlmUniqueID><ISSNLinking>0947-0867</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>9</Month><Day>13</Day><Hour>6</Hour><Minute>35</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>9</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>14</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>9</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34511734</ArticleId><ArticleId IdType="pmc">PMC8417673</ArticleId><ArticleId IdType="doi">10.1007/s12268-021-1620-6</ArticleId><ArticleId IdType="pii">1620</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Puntmann VO, Carerj ML, Wieters I, et al. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19) JAMA Cardiol. 2020;5:1265&#x2013;1273. doi: 10.1001/jamacardio.2020.3557.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.3557</ArticleId><ArticleId IdType="pmc">PMC7385689</ArticleId><ArticleId IdType="pubmed">32730619</ArticleId></ArticleIdList></Reference><Reference><Citation>Gro&#xdf; S, Jahn C, Cushman S, et al. SARS-CoV-2 receptor ACE2-dependent implications on the cardiovascular system: from basic science to clinical implications. J Mol Cell Cardiol. 2020;144:47&#x2013;53. doi: 10.1016/j.yjmcc.2020.04.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yjmcc.2020.04.031</ArticleId><ArticleId IdType="pmc">PMC7191280</ArticleId><ArticleId IdType="pubmed">32360703</ArticleId></ArticleIdList></Reference><Reference><Citation>Viereck J, Thum T. Circulating noncoding RNAs as biomarkers of cardiovascular disease and injury. Circ Res. 2017;120:381&#x2013;399. doi: 10.1161/CIRCRESAHA.116.308434.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.116.308434</ArticleId><ArticleId IdType="pubmed">28104771</ArticleId></ArticleIdList></Reference><Reference><Citation>Batkai S, Genschel C, Viereck J, et al. CDR132L improves systolic and diastolic function in a large animal model of chronic heart failure. Eur Heart J. 2021;42:192&#x2013;201. doi: 10.1093/eurheartj/ehaa791.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehaa791</ArticleId><ArticleId IdType="pmc">PMC7813625</ArticleId><ArticleId IdType="pubmed">33089304</ArticleId></ArticleIdList></Reference><Reference><Citation>T&#xe4;ubel J, Hauke W, Rump S, et al. Novel antisense therapy targeting microRNA-132 in patients with heart failure: Results of a first-in-human Phase 1b randomized, double-blind, placebo-controlled study. Eur Heart J. 2021;42:178&#x2013;188. doi: 10.1093/eurheartj/ehaa898.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehaa898</ArticleId><ArticleId IdType="pmc">PMC7954267</ArticleId><ArticleId IdType="pubmed">33245749</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu D, Chatterjee S, Xiao K, et al. MicroRNAs targeting the SARS-CoV-2 entry receptor ACE2 in cardiomyocytes. J Mol Cell Cardiol. 2020;148:46&#x2013;49. doi: 10.1016/j.yjmcc.2020.08.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yjmcc.2020.08.017</ArticleId><ArticleId IdType="pmc">PMC7470794</ArticleId><ArticleId IdType="pubmed">32891636</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalo-Calvo D De, Vea A, B&#xe4;r C et al. Circulating non-coding RNAs in biomarker-guided cardiovascular therapy: A novel tool for personalized medicine? Eur Heart J 40: 1643&#x2013;1650</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6528150</ArticleId><ArticleId IdType="pubmed">29688487</ArticleId></ArticleIdList></Reference><Reference><Citation>Garg A, Seeliger B, Derda AA, et al. Circulating cardiovascular microRNAs in critically ill COVID-19 patients. Eur J Heart Fail. 2021;23:468&#x2013;475. doi: 10.1002/ejhf.2096.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejhf.2096</ArticleId><ArticleId IdType="pmc">PMC8014268</ArticleId><ArticleId IdType="pubmed">33421274</ArticleId></ArticleIdList></Reference><Reference><Citation>The L. Facing up to long COVID. Lancet. 2020;396:1861. doi: 10.1016/S0140-6736(20)32662-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32662-3</ArticleId><ArticleId IdType="pmc">PMC7834723</ArticleId><ArticleId IdType="pubmed">33308453</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>